Last $172.27 USD
Change Today +0.18 / 0.10%
Volume 519.7K
ILMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 2:41 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for illumina inc (ILMN)

Year over year, Illumina Inc. has seen their bottom line shrink from $151.3M USD to $125.3M USD despite an increase in revenues from $1.1B USD to $1.4B USD. An increase in the percentage of sales devoted to cost of goods sold from 31.42% to 31.70% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Jan 02
2011
Reclassified
Jan 01
2012
Reclassified
Dec 30
2012
Reclassified
Dec 29
2013
4 Year
Trend
Revenues902.71,055.51,148.51,421.2
TOTAL REVENUES902.71,055.51,148.51,421.2
Cost of Goods Sold293.4334.3360.8450.5
GROSS PROFIT609.3721.2787.7970.7
Selling General & Admin Expenses, Total235.2280.3324.8381.6
R&D Expenses159.6174.7184.8276.2
Depreciation & Amortization, Total7.812.114.233.6
OTHER OPERATING EXPENSES, TOTAL402.5467.1523.7691.4
OPERATING INCOME206.8254.1264.0279.3
Interest Expense-24.6-34.8-37.8-39.7
Interest and Investment Income8.47.116.24.9
NET INTEREST EXPENSE-16.2-27.7-21.6-34.8
Currency Exchange Gains (Loss)-----2.5-0.8
Other Non-Operating Income (Expenses)0.3-1.1--0.0
EBT, EXCLUDING UNUSUAL ITEMS190.8225.3239.9243.7
Merger & Restructuring Charges8.5-50.9-32.6-16.2
Gain (Loss) on Sale of Investments-10.3--45.961.4
Other Unusual Items, Total-3.7-41.4-30.6-129.5
Legal Settlements--2.3---115.4
Other Unusual Items-3.7-43.7-9.2-14.2
EBT, INCLUDING UNUSUAL ITEMS185.4133.0222.6159.3
Income Tax Expense60.546.471.434.0
Earnings from Continuing Operations124.986.6151.3125.3
NET INCOME124.986.6151.3125.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS124.986.6151.3125.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS124.986.6151.3125.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $172.27 USD +0.18

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $168.63 USD +2.16
Avago Technologies Ltd $76.20 USD -0.07
Sigma-Aldrich Corp $103.66 USD -0.21
UCB SA €73.33 EUR -0.17
Vertex Pharmaceuticals Inc $90.38 USD +1.39
View Industry Companies
 

Industry Analysis

ILMN

Industry Average

Valuation ILMN Industry Range
Price/Earnings 100.0x
Price/Sales 13.9x
Price/Book 22.2x
Price/Cash Flow 93.7x
TEV/Sales 13.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.